Literature DB >> 16610242

GH-binding protein is related to bone mineral density in non-obese androgenized women.

M Legan1, J Osredkar, S Fisker, A Kocijancic.   

Abstract

GH and IGF system components are important regulators of bone formation and at the same time pathogenetic factors in functional hyperandrogenism (FH) in lean females. We studied the relationships between bone mineral density (BMD) and serum concentrations of GH, GH-related parameters, androgens and estrogen, in 18 non-obese women of reproductive age with functional hyperandrogenism compared to a group of 10 healthy eumenorrheic age- and weight-matched women. In androgenized women, a significant positive correlation was found between BMD and GH-binding protein (GHBP), whereas BMD did not correlate to GH or other related parameters. It is suggested that higher tissue GH receptor responsiveness in non-obese androgenized women may contribute to their higher BMD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16610242     DOI: 10.1007/BF03344089

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

1.  Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.

Authors:  T Sugimoto; K Nishiyama; F Kuribayashi; K Chihara
Journal:  J Bone Miner Res       Date:  1997-08       Impact factor: 6.741

2.  Bone mass in hirsute women with androgen excess.

Authors:  J E Dixon; A Rodin; B Murby; M G Chapman; I Fogelman
Journal:  Clin Endocrinol (Oxf)       Date:  1989-03       Impact factor: 3.478

3.  Effects of recombinant human insulin-like growth factor (IGF)-I and estrogen administration on IGF-I, IGF binding protein (IGFBP)-2, and IGFBP-3 in anorexia nervosa: a randomized-controlled study.

Authors:  Steven Grinspoon; Karen Miller; David Herzog; David Clemmons; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2003-03       Impact factor: 5.958

Review 4.  Growth hormone, insulin-like growth factor I, and bone: a clinical review.

Authors:  A G Johansson; E Lindh; S Ljunghall
Journal:  J Intern Med       Date:  1993-12       Impact factor: 8.989

Review 5.  Recombinant human growth hormone as potential therapy for osteoporosis.

Authors:  R Marcus
Journal:  Baillieres Clin Endocrinol Metab       Date:  1998-07

Review 6.  Clinical review 112: Does serum growth hormone (GH) binding protein reflect human GH receptor function?

Authors:  T Amit; M B Youdim; Z Hochberg
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

7.  Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis.

Authors:  Anthony J Donaghy; Patric J D Delhanty; Ken K Ho; Roger Williams; Robert C Baxter
Journal:  J Hepatol       Date:  2002-06       Impact factor: 25.083

8.  Measurement of human growth hormone receptor messenger ribonucleic acid by a quantitative polymerase chain reaction-based assay: demonstration of reduced expression after elective surgery.

Authors:  M Hermansson; R B Wickelgren; F Hammarqvist; R Bjarnason; I Wennström; J Wernerman; B Carlsson; L M Carlsson
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

Review 9.  Involvement of growth factors in the pathophysiology of polycystic ovary syndrome.

Authors:  R Homburg
Journal:  Gynecol Endocrinol       Date:  1998-12       Impact factor: 2.260

10.  Gene expression of the GH receptor in subcutaneous and intraabdominal fat in healthy females: relationship to GH-binding protein.

Authors:  Sanne Fisker; Betina Hansen; Jens Fuglsang; Kurt Kristensen; Per Ovesen; Hans Ørskov; Jens Otto Lunde Jørgensen
Journal:  Eur J Endocrinol       Date:  2004-06       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.